{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:50:14Z","timestamp":1770216614563,"version":"3.49.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ijcard.2004.05.004","type":"journal-article","created":{"date-parts":[[2004,7,7]],"date-time":"2004-07-07T21:23:59Z","timestamp":1089235439000},"page":"321-333","source":"Crossref","is-referenced-by-count":17,"title":["Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy"],"prefix":"10.1016","volume":"96","author":[{"given":"Lip-Bun","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Schlosshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2004.05.004_bib1","first-page":"1P","article-title":"Symposium on aldosterone","volume":"83","author":"Tait","year":"1979","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02158515","article-title":"Konstitution des Aldosterons, des neuen Mineralocorticoids","volume":"10","author":"Simpson","year":"1954","journal-title":"Experientia"},{"key":"10.1016\/j.ijcard.2004.05.004_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/hlca.19540370423","article-title":"Aldosterone. Isolierung und Eigenschaften. Ueber Bestandteile der Nebennierenrinde und verwandte Stoffe. 91. Mitteilung","volume":"37","author":"Simpson","year":"1954","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ijcard.2004.05.004_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hlca.19540370424","article-title":"Die Konstitution des Aldosterons. Ueber Bestandteile der Nebennierenrinde und verwandte Stoffe. 92. Mitteilung","volume":"37","author":"Simpson","year":"1954","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ijcard.2004.05.004_bib5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.steroids.2003.09.006","article-title":"Aldosterone and aldosteronism","volume":"68","author":"Horton","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.ijcard.2004.05.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2003.10.004","article-title":"The discovery, isolation and identification of aldosterone: reflections on emerging regulation and function","volume":"217","author":"Tait","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.ijcard.2004.05.004_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(52)92427-6","article-title":"The effect of adrenal extract on mineral metabolism","volume":"1","author":"Tait","year":"1952","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2004.05.004_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02155834","article-title":"Isolierung eines neuen krystallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineralstoffwechsel","volume":"9","author":"Simpson","year":"1953","journal-title":"Experientia"},{"key":"10.1016\/j.ijcard.2004.05.004_bib9","article-title":"English translation of abstracts of original articles published in German 50 years ago on the discovery of aldosterone","volume":"94","author":"Schlosshan","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2004.05.004_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(03)13869-X","article-title":"Demographics and concomitant disorders in heart failure","volume":"362","author":"Krum","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2004.05.004_bib14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement (SAVE) Study","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib15","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"Kober","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib16","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"The CAPRICORN Investigators","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2004.05.004_bib17","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0002-9149(00)00777-3","article-title":"Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction","volume":"85","author":"Aronow","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib18","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1111\/j.1540-8159.1997.tb06104.x","article-title":"Use of left ventricular ejection fraction or wall-motion score index in predicting arrhythmic death in patients following an acute myocardial infarction. The TRACE Study Group","volume":"20","author":"Kober","year":"1997","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib19","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1161\/01.CIR.96.10.3294","article-title":"Cardiovascular death and left ventricular remodeling two years after myocardial infarction: Baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial","volume":"96","author":"Sutton","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib20","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1161\/hc4601.099485","article-title":"Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease","volume":"104","author":"Heitzer","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib21","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mhj.2002.129969","article-title":"Aldosterone: cardiovascular assault","volume":"144","author":"Struthers","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.CIR.78.2.376","article-title":"Neurohumoral responses to chronic myocardial infarction in rats","volume":"78","author":"Hodsman","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/hrt.60.2.117","article-title":"Neuroendocrine activation after acute myocardial infarction","volume":"60","author":"McAlpine","year":"1988","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.RES.69.2.475","article-title":"Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure","volume":"69","author":"Hirsch","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2004.05.004_bib25","doi-asserted-by":"crossref","first-page":"80D","DOI":"10.1016\/0002-9149(91)90264-L","article-title":"Activation of neurohumoral systems following acute myocardial infarction","volume":"68","author":"Rouleau","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib26","first-page":"H1630","article-title":"Stretch-mediated activation of cardiac renin gene","volume":"267","author":"Boer","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib27","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.92.9.2690","article-title":"Cardiac renin-angiotensin system in the hypertrophied heart","volume":"92","author":"Iwai","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib28","first-page":"H1040","article-title":"Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction","volume":"271","author":"Passier","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/jmcc.1993.1017","article-title":"Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat","volume":"25","author":"Lindpaintner","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib30","first-page":"H1268","article-title":"Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction","volume":"269","author":"Passier","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib31","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1006\/jmcc.1993.1149","article-title":"Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats","volume":"25","author":"Yamagishi","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/jmcc.1996.0039","article-title":"Regional changes in angiotensin II receptor density after experimental myocardial infarction","volume":"28","author":"Lefroy","year":"1996","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.ph.55.030193.000555","article-title":"Aldosterone action","volume":"55","author":"Funder","year":"1993","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1152\/advan.00051.2001","article-title":"Aldosterone","volume":"26","author":"Booth","year":"2002","journal-title":"Adv. Physiol. Educ."},{"key":"10.1016\/j.ijcard.2004.05.004_bib35","first-page":"310","article-title":"Aldosterone antagonists: current and future perspectives","volume":"2","author":"Williams","year":"2000","journal-title":"Curr. Opin. Cardiovasc. Pulm. Ren. Investig. Drugs"},{"key":"10.1016\/j.ijcard.2004.05.004_bib36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/endo-69-4-673","article-title":"Stimulation of active Na transport across isolated toad bladder after injection of aldosterone to the animal","volume":"69","author":"Crabbe","year":"1961","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2004.05.004_bib38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.ph.50.030188.002205","article-title":"Regulation of aldosterone secretion","volume":"50","author":"Quinn","year":"1988","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.me.20.020169.001255","article-title":"Mechanism of action of aldosterone","volume":"20","author":"Fanestil","year":"1969","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev.ph.43.030181.003225","article-title":"Steroid hormones and the kidney","volume":"43","author":"Fanestil","year":"1981","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-4731(72)90052-0","article-title":"Specific aldosterone binding in rat kidney and parotid","volume":"3","author":"Funder","year":"1972","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.ijcard.2004.05.004_bib42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor","volume":"71","author":"Lombes","year":"1992","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2004.05.004_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/01.CIR.92.2.175","article-title":"Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart","volume":"92","author":"Lombes","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib44","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","article-title":"Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation","volume":"273","author":"Silvestre","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2004.05.004_bib45","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1210\/mend-3-11-1877","article-title":"Molecular cloning of a mineralocorticoid (type I) receptor complementary DNA from rat hippocampus","volume":"3","author":"Patel","year":"1989","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.HYP.29.1.45","article-title":"Vascular aldosterone in genetically hypertensive rats","volume":"29","author":"Takeda","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2004.05.004_bib47","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1210\/en.138.8.3369","article-title":"Aldosterone biosynthesis in the rat brain","volume":"138","author":"Gomez-Sanchez","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2004.05.004_bib48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1677\/jme.0.0240321","article-title":"Expression of 11\u00df-hydroxylase and aldosterone synthase genes in the rat brain","volume":"24","author":"MacKenzie","year":"2000","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib49","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","article-title":"Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells","volume":"269","author":"Hatakeyama","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2004.05.004_bib50","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1210\/jc.81.8.2797","article-title":"Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin","volume":"81","author":"Takeda","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2004.05.004_bib51","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.HYP.33.4.1025","article-title":"Local renin-angiotensin system is involved in K+-induced aldosterone secretion from human adrenocortical NCI-H295 cells","volume":"33","author":"Hilbers","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2004.05.004_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/CS20000263","article-title":"Angiotensin receptors: distribution, signalling and function","volume":"100","author":"Dinh","year":"2001","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijcard.2004.05.004_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-2143(03)00062-3","article-title":"Aldosteronism revisited: Perspectives on less well-recognized actions of aldosterone","volume":"142","author":"Weber","year":"2003","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib54","first-page":"3795","article-title":"Evidence for the existence of a functional cardiac renin-angiotensin system in humans","volume":"96","author":"Danser","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib55","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","article-title":"Activation of cardiac aldosterone production in rat myocardial infarction. Effect of angiotensin II receptor blockade and role in cardiac fibrosis","volume":"99","author":"Silvestre","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2004.05.004_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.CIR.103.1.72","article-title":"Aldosterone production is activated in failing ventricle in humans","volume":"103","author":"Mizuno","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.CIR.104.2.137","article-title":"Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes","volume":"104","author":"Harada","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0002-9149(94)90362-X","article-title":"The association of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study)","volume":"74","author":"Tsuji","year":"1994","journal-title":"Am. J. Cardiol."},{"issue":"6 Pt 2","key":"10.1016\/j.ijcard.2004.05.004_bib59","first-page":"H1818","article-title":"Active renin and angiotensinogen in cardiac interstitial fluid after myocardial infarction","volume":"276","author":"Hirsch","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib60","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9149(90)90476-H","article-title":"Role of left ventricular dysfunction in selective neurohormonal activation in the recovery phase of anterior wall acute myocardial infarction","volume":"66","author":"Vaughan","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib61","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib62","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Antialdosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib63","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone","volume":"26","author":"Brilla","year":"1994","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mhj.2001.111258","article-title":"Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction","volume":"141","author":"Modena","year":"2001","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib65","series-title":"Myocardial Infarction: From Trials to Practice","first-page":"25","article-title":"Why does the heart remodel after myocardial infarction?","author":"Tan","year":"1995"},{"key":"10.1016\/j.ijcard.2004.05.004_bib66","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.RES.69.5.1185","article-title":"Cardiac myocyte necrosis induced by angiotensin II","volume":"69","author":"Tan","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2004.05.004_bib67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/hrt.72.4.315","article-title":"Cardiac Remodelling","volume":"72","author":"Tan","year":"1994","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-2999(00)00384-8","article-title":"Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition","volume":"400","author":"Verhagen","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.HYP.32.3.527","article-title":"Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland","volume":"32","author":"Usui","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2004.05.004_bib70","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/en.141.10.3871","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2004.05.004_bib71","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.0000097000.51723.6F","article-title":"Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II\/NG-nitro-l-arginine methyl ester-induced myocardial injury","volume":"108","author":"Oestreicher","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib72","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/hyp.39.2.614","article-title":"Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading","volume":"39","author":"Martinez","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2004.05.004_bib73","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1006\/jmcc.2002.2115","article-title":"Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat","volume":"34","author":"De Angelis","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1113\/eph8802549","article-title":"Cardiomyocyte death and the ageing and failing heart","volume":"88","author":"Goldspink","year":"2003","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib75","doi-asserted-by":"crossref","DOI":"10.1113\/expphysiol.2004.027482","article-title":"Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: The same or separate death pathways?","volume":"89","author":"Goldspink","year":"2004","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib76","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am. J. Physiol, Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2003.10.004","article-title":"From CONSENSUS to CHARM\u2014How do ACEI and ARB produce clinical benefits in CHF?","volume":"94","author":"Tan","year":"2004","journal-title":"Int. J. Cardiol."},{"issue":"2 Part 2","key":"10.1016\/j.ijcard.2004.05.004_bib78","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2004.05.004_bib79","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib80","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1291\/hypres.22.17","article-title":"Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension","volume":"22","author":"Sato","year":"1999","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ijcard.2004.05.004_bib82","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib83","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"The Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib84","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2004.05.004_bib85","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2004.05.004_bib86","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2004.05.004_bib87","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib88","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin 1\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0922-4106(95)90018-7","article-title":"Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1\u00df","volume":"290","author":"Ikeda","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib90","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib91","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib92","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1388-9842(02)00205-2","article-title":"Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function","volume":"5","author":"van Kraaij","year":"2003","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2004.05.004_bib93","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/cs0590443","article-title":"Hemodynamic and hormone responses to acute and chronic furosemide therapy in congestive heart failure","volume":"59","author":"Ikram","year":"1980","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijcard.2004.05.004_bib94","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/0002-9149(87)90615-1","article-title":"Identification of normal neuroendocrine activity in mild congestive heart failure: a stimulating effect of upright posture and diuretics","volume":"60","author":"Kubo","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/hrt.57.1.17","article-title":"Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics","volume":"57","author":"Bayliss","year":"1987","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-103-1-1","article-title":"Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure","volume":"103","author":"Francis","year":"1985","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib97","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1136\/hrt.72.2_Suppl.S51","article-title":"Neuroendocrine effects of diuretics in heart failure","volume":"72","author":"van Zwieten","year":"1994","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib98","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0008-6363(96)00134-4","article-title":"Vascular effects of loop diuretics","volume":"32","author":"Dormans","year":"1996","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2004.05.004_bib99","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1253\/jcj.46.552","article-title":"Renin response to furosemide differs with the routes of administration in healthy men","volume":"46","author":"Noda","year":"1982","journal-title":"Jpn. J. Circ."},{"key":"10.1016\/j.ijcard.2004.05.004_bib100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.63.3.645","article-title":"Relation of the renin\u2013angiotensin\u2013aldosterone system to clinical state in congestive heart failure","volume":"63","author":"Dzau","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib101","first-page":"273","article-title":"Diuretics as initial and sole treatment in chronic cardiac failure","volume":"2","author":"Anand","year":"1991","journal-title":"Cardioscience"},{"key":"10.1016\/j.ijcard.2004.05.004_bib102","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.HYP.26.1.137","article-title":"Effects of furosemide and verapamil on the NaCl dependency of macula densa-mediated renin secretion","volume":"26","author":"He","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2004.05.004_bib103","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1476-5381.1984.tb10785.x","article-title":"Frusemide releases renin in the rat kidney when prostacyclin synthesis is suppressed","volume":"82","author":"Barden","year":"1984","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib104","first-page":"189","article-title":"Comparison of effects of locally infused angiotensin I and II on hand veins and forearm arteries in man: evidence for converting enzyme activity in limb vessels","volume":"47","author":"Collier","year":"1974","journal-title":"Clin. Sci. Mol. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2125.1989.tb05370.x","article-title":"Comparison of the acute renal and peripheral vascular responses to frusemide and bumetanide at low and high dose","volume":"27","author":"Passmore","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib106","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI112456","article-title":"Sodium and water balance in chronic congestive heart failure","volume":"77","author":"Cody","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2004.05.004_bib107","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.0000124064.00494.21","article-title":"Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart Failure","volume":"109","author":"Cataliotti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib108","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0002-9343(72)90054-X","article-title":"Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease","volume":"52","author":"Laragh","year":"1972","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2004.05.004_bib109","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/hrt.42.3.316","article-title":"Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease","volume":"42","author":"Knight","year":"1979","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1749-6632.1966.tb41219.x","article-title":"Physiologic and clinical observations on frusemide and ethacrynic acid","volume":"139","author":"Laragh","year":"1966","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"2 Part 2","key":"10.1016\/j.ijcard.2004.05.004_bib111","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.HYP.37.2.806","article-title":"K+ depletion and the progression of hypertensive disease or heart failure. The pathogenic role of diuretic-induced aldosterone secretion","volume":"37","author":"Laragh","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2004.05.004_bib112","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.0954-6820.1987.tb10664.x","article-title":"Plasma and skeletal muscle electrolytes in patients on long-term diuretic therapy for arterial hypertension and\/or congestive heart failure","volume":"222","author":"Dyckner","year":"1987","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.ijcard.2004.05.004_bib113","doi-asserted-by":"crossref","first-page":"44K","DOI":"10.1016\/0002-9149(90)91279-F","article-title":"Relation of cardiovascular disease to potassium and magnesium deficiencies","volume":"65","author":"Dyckner","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib114","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0002-8703(92)90633-7","article-title":"Magnesium deficiency and sudden death","volume":"124","author":"Lisenberg","year":"1992","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-8703(74)90355-X","article-title":"Electrolyte and antiarrhythmic drug interaction","volume":"88","author":"Dreifus","year":"1974","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib116","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/heart.89.4.411","article-title":"Serum magnesium aberrations in furosemide (frusemide) treated patients with congestive heart failure: pathophysiological correlates and prognostic evaluation","volume":"89","author":"Cohen","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2004.05.004_bib117","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0735-1097(10)80329-8","article-title":"Prognostic importance of the serum magnesium concentration in patients with congestive heart failure","volume":"16","author":"Gottlieb","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib118","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0735-1097(93)90095-I","article-title":"Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study","volume":"21","author":"Eichhorn","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib119","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0002-8703(93)90754-W","article-title":"Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure","volume":"125","author":"Gottlieb","year":"1993","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib120","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/0002-8703(94)90633-5","article-title":"Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia","volume":"128","author":"Leier","year":"1994","journal-title":"Am. Heart J."},{"issue":"7780","key":"10.1016\/j.ijcard.2004.05.004_bib121","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(72)92018-1","article-title":"Fate of potassium supplements in six outpatients receiving long-term diuretics for oedematous disease","volume":"2","author":"Down","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2004.05.004_bib122","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-8703(72)90305-5","article-title":"Exchangeable potassium in heart disease: long-term effects of potassium supplements and amiloride","volume":"84","author":"Croxson","year":"1972","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib123","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/hrt.35.4.456","article-title":"Use of amiloride as a potassium conserving agent in severe heart disease","volume":"35","author":"Davidson","year":"1973","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib124","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2265.1977.tb01307.x","article-title":"Amiloride in the treatment of primary hyperaldosteronism and essential hypertension","volume":"7","author":"Kremer","year":"1977","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib125","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/bmj.3.5827.620","article-title":"Magnesium deficiency in patients on long-term diuretic therapy for heart failure","volume":"3","author":"Lim","year":"1972","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib126","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bmj.1.6116.822-a","article-title":"Intracellular potassium after magnesium infusion","volume":"1","author":"Dyckner","year":"1978","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib127","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.0954-6820.1981.tb02651.x","article-title":"The effect of diuretics on lymphocyte magnesium and potassium","volume":"647","author":"Ryan","year":"1981","journal-title":"Acta Med. Scand., Suppl."},{"key":"10.1016\/j.ijcard.2004.05.004_bib128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2125.1992.tb04046.x","article-title":"Intracellular free magnesium in lymphocytes from patients with congestive cardiac failure treated with loop diuretics with and without amiloride","volume":"33","author":"Ng","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib129","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/hy1101.095010","article-title":"Blood pressure responses to small doses of amiloride and spironolactone in normotensive subjects","volume":"38","author":"Pratt","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2004.05.004_bib130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/endo-90-1-299","article-title":"Further studies of the influence of potassium upon aldosterone production in the rat","volume":"90","author":"Boyd","year":"1972","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2004.05.004_bib131","first-page":"S149","article-title":"Various approaches to blockade of the renin\u2013angiotensin system: persistent renin response","volume":"8","author":"Brunner","year":"1990","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2004.05.004_bib132","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/00004872-200105000-00001","article-title":"Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift","volume":"19","author":"Epstein","year":"2001","journal-title":"J. Hypertens."},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2004.05.004_bib133","first-page":"A38","article-title":"The selective aldosterone blocker eplerenone is effective as monotherapy or adjuvant therapy in diuretic hypertensives with microalbuminuria","volume":"51","author":"Bucksalew","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2004.05.004_bib134","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000077396","article-title":"Aldosterone Antagonism Ameliorates Proteinuria and Nephrosclerosis Independent of Glomerular Dynamics in l-NAME\/SHR Model","volume":"24","author":"Zhou","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000075945","article-title":"Effects of eplerenone on heart and kidney in two-kidney, one-clip rats","volume":"24","author":"Hao","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib136","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1388-9842(99)00046-X","article-title":"Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study","volume":"1","author":"Lee","year":"1999","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2004.05.004_bib137","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/147323000102900103","article-title":"Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy","volume":"29","author":"Sato","year":"2001","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ijcard.2004.05.004_bib138","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","article-title":"Rise in plasma concentration of aldosterone during long-term angiotensin II suppression","volume":"91","author":"Staessen","year":"1981","journal-title":"J. Endocrinol."},{"issue":"9 Pt 1","key":"10.1016\/j.ijcard.2004.05.004_bib139","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0895-7061(03)00913-0","article-title":"Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy","volume":"16","author":"Sato","year":"2003","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ijcard.2004.05.004_bib140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/j.1552-4604.1993.tb03901.x","article-title":"Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors","volume":"33","author":"Borghi","year":"1993","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib141","doi-asserted-by":"crossref","first-page":"F843","DOI":"10.1152\/ajprenal.00110.2003","article-title":"Regulation of NHE3, NKCC2, and NCC abundance in kidney during aldosterone escape phenomenon: role of NO","volume":"285","author":"Turban","year":"2003","journal-title":"Am. J. Physiol., Renal. Physiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib142","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/hrt.52.5.530","article-title":"Captopril in heart failure: a double blind controlled trial","volume":"52","author":"Cleland","year":"1984","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib143","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/hrt.82.1.57","article-title":"How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?","volume":"82","author":"MacFadyen","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2004.05.004_bib144","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparison of candesartan, enalapril and their combination in congestive heart failure. Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study. The RESOLVD Pilot Study Investigators","volume":"100","author":"McKelvie","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib145","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.CIR.0000030935.89559.04","article-title":"Elevated plasma aldosterone levels despite complete inhibition. of the vascular angiotensin-converting enzyme in chronic heart failure","volume":"106","author":"Jorde","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2004.05.004_bib146","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/euhj.1998.1093","article-title":"Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study","volume":"19","author":"Vantrimpont","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib147","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9149(01)02261-5","article-title":"Relation of aldosterone \u201cescape\u201d despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"89","author":"Cicoira","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2004.05.004_bib148","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1527-5299.2003.02397.x","article-title":"Hyperkalemia, congestive heart failure, and aldosterone receptor antagonism","volume":"9","author":"Sica","year":"2003","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.ijcard.2004.05.004_bib149","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0002-8703(96)90365-8","article-title":"Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators","volume":"131","author":"Kostis","year":"1996","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2004.05.004_bib150","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/j.1523-1755.2000.00381.x","article-title":"ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure","volume":"58","author":"Bakris","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijcard.2004.05.004_bib151","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4037\/ajcc2004.13.2.162","article-title":"The resurrection of spironolactone on its golden anniversary","volume":"13","author":"Futterman","year":"2004","journal-title":"Am. J. Crit. Care"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527304003705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527304003705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T20:51:40Z","timestamp":1705179100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527304003705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":151,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0167527304003705"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2004.05.004","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}